Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study

  • Hao Wang1,
  • Lucille J. Russell2,
  • Kathleen M. Kelly2,
  • Steven Wang2 and
  • John Thipphawong2Email author
BMC UrologyBMC series – open, inclusive and trusted201717:2

https://doi.org/10.1186/s12894-016-0193-z

Received: 10 November 2015

Accepted: 14 December 2016

Published: 5 January 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
10 Nov 2015 Submitted Original manuscript
18 Mar 2016 Reviewed Reviewer Report - A Giannantoni
27 Sep 2016 Reviewed Reviewer Report - P. C. Bosch
30 Nov 2016 Author responded Author comments - Hao Wang
Resubmission - Version 2
30 Nov 2016 Submitted Manuscript version 2
Publishing
14 Dec 2016 Editorially accepted
5 Jan 2017 Article published 10.1186/s12894-016-0193-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Office of Translational Research, National Institute of Neurological Disorders and Stroke (NINDS)
(2)
Janssen Research & Development, LLC

Advertisement